• Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

    ソース: Nasdaq GlobeNewswire / 12 12 2023 06:00:00   America/Chicago

    N/A
シェアする